Publicacións nas que colabora con José Castillo Sánchez (56)

2024

  1. Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

    iScience, Vol. 27, Núm. 11

2021

  1. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

  3. Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015

    European Neurology, Vol. 84, Núm. 1, pp. 16-21

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

  2. Glutamate neurotoxicity is involved in the neurological damage in patients undergoing extracorporeal circulation

    International Journal of Cardiology, Vol. 172, Núm. 2, pp. 481-483

  3. Guía para el tratamiento del infarto cerebral agudo

    Neurologia

  4. Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico

    Neurologia

  5. Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: A systematic review and meta-analysis

    Journal of Neuroimmunology, Vol. 274, Núm. 1-2, pp. 215-224

2013

  1. Guías de actuación clínica en la hemorragia intracerebral

    Neurologia

  2. Interleukin-10 facilitates the selection of patients for systemic thrombolysis

    BMC Neurology, Vol. 13

2012

  1. A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA)

    Clinical Science, Vol. 122, Núm. 3, pp. 113-119

  2. Definición y control de factores deriesgo en el superviviente a un ictus. Réplica

    Revista de Neurologia

  3. Guía para el tratamiento preventivo del ictus isquémico y AIT (I). Actuación sobre los factores de riesgo y estilo de vida

    Neurologia

  4. Protocolos de actuación en el Área Neurovascular. Xerencia de Xestión Integrada de Santiago de Compostela

    Conselleria de Sanidade

2011

  1. Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels

    Clinical Science, Vol. 121, Núm. 1, pp. 11-17

  2. Características clínicas y pronóstico de pacientes con enfermedad cerebrovascular crónica (estudio ICBAR)

    Revista de Neurologia, Vol. 53, Núm. 8, pp. 449-456

  3. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke

    Stroke, Vol. 42, Núm. 10, pp. 2813-2818

  4. High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1387-1393

  5. Impaired brachial flow-mediated dilation is a predictor of a new-onset vascular event after stroke

    Cerebrovascular Diseases, Vol. 32, Núm. 2, pp. 155-162